Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sonoma Pharmaceuticals, Inc.

3.56
-0.0500-1.39%
Volume:33.28K
Turnover:119.43K
Market Cap:5.85M
PE:-1.28
High:3.69
Open:3.65
Low:3.50
Close:3.61
Loading ...

The early winner in the 'Dexit' war for corporate relocations: Nevada

Yahoo Finance
·
10 Jul

Sonoma Pharmaceuticals Shares up 7.8% at $3.18 in After the Bell Trading Following Results

THOMSON REUTERS
·
18 Jun

Sonoma Pharmaceuticals FY Ebitda USD -3.3 Million

THOMSON REUTERS
·
18 Jun

Sonoma Pharmaceuticals Reports 15% Decline in U.S. Revenue, 16% Growth in European Sales for Fiscal Year Ending March 31, 2025

Reuters
·
18 Jun

Crude Oil Falls Over 3%; Philip Morris Earnings Top Views

Benzinga
·
24 Apr

Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket

Benzinga
·
23 Apr

Sonoma Pharmaceuticals Poised to Sell Acne Products in UK; Shares Soar Premarket

MT Newswires Live
·
23 Apr

Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain

ACCESS Newswire
·
23 Apr

Fast-paced Momentum Stock Sonoma Pharmaceuticals (SNOA) Is Still Trading at a Bargain

Zacks
·
27 Mar

Delaware passes law designed to stop more Elon Musks from leaving state

Yahoo Finance
·
27 Mar

Wall Street Stabilizes, Driving Quiet Premarket Action for US Equity Futures

MT Newswires Live
·
11 Mar

Why Fast-paced Mover Sonoma Pharmaceuticals (SNOA) Is a Great Choice for Value Investors

Zacks
·
11 Mar

Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)

ACCESS Newswire
·
11 Mar

Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando

ACCESS Newswire
·
26 Feb

More Musk-like 'Dexits' pose fresh threat to Delaware's corporation crown

Yahoo Finance
·
15 Feb

Sonoma Pharmaceuticals Third Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
07 Feb

Sonoma Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
07 Feb

Sonoma Pharmaceuticals Q3 2025 GAAP EPS $(0.63) Beats $(0.69) Estimate, Sales $3.564 Miss $4.060M Estimate

Benzinga
·
06 Feb

Sonoma Pharmaceuticals Inc expected to post a loss of 69 cents a share - Earnings Preview

Reuters
·
05 Feb